2016
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
Mosquirix
|
|
|
PfSPZ vaccine
|
|
|
Mumps Vaccine
|
|
|
Poliomyelitis Vaccine
|
Detailed explanation-1: -The RTS, S malaria vaccine is the result of 30 years of research and development by GSK and through a partnership with PATH, with support from a network of African research centres. The Bill & Melinda Gates Foundation provided catalytic funding for late-stage development of RTS, S between 2001 and 2015.
Detailed explanation-2: -This new vaccine, called R21, is potentially an improved version of another vaccine, called RTS, S, which the World Health Organization approved last October for broad use in regions with significant malaria transmission. RTS, S was the first-ever vaccine for a human parasitic infection.
Detailed explanation-3: -RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine. It is the only malaria vaccine approved and in wide use.
Detailed explanation-4: -Mosquirix is a vaccine that is given to children aged 6 weeks to 17 months to help protect against malaria caused by the parasite Plasmodium falciparum.